Zepbound, the new GLP-1 weight-loss drug from Eli Lilly & Co., has been approved by the Food and Drug Administration for ...

The FDA said studies have shown that by aiding weight loss, Zepbound improves sleep apnea symptoms in some patients.

The US Food and Drug Administration on Friday approved the first prescription medicine for obstructive sleep apnea: the ...

This weight-loss drug, designed for obese patients, significantly reduces breathing disruptions and offers a new treatment ...

"Zepbound is the first medication that significantly improves moderate-to-severe OSA and aids in long-term weight loss in adults with obesity." ...

The crew of a military helicopter flying out of Camp Pendleton made a fiery but non-injury emergency landing alongside Interstate 5 north of Oceanside. Proceeds from ABC7-inspired merchandise ...